LIPTAK ROBERT

CIK 000125252313 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001252523

Recent Transactions

50 trades

Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2019-01-22+25,000→ 25,000 total
Conversion
Entasis Therapeutics Holdings Inc.
Series B-1 Tranche B Convertible Preferred Stock
2018-09-28−8,552,024→ 0 total
Conversion
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28+361,829→ 361,829 total
Purchase
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28$15.00/sh+453,395→ 1,623,405 total
Conversion
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28+323,341→ 685,170 total
Conversion
Entasis Therapeutics Holdings Inc.
Common Stock
2018-09-28+412,583→ 1,170,010 total
Conversion
Entasis Therapeutics Holdings Inc.
Series B-1 Tranche A Convertible Preferred Stock
2018-09-28−6,702,213→ 0 total
Conversion
Entasis Therapeutics Holdings Inc.
Series B Convertible Preferred Stock
2018-09-28−7,500,000→ 0 total
Conversion
Forty Seven, Inc.
Series A-2 Preferred Stock
2018-07-02−755,780→ 0 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+755,780→ 1,694,269 total
Conversion
Forty Seven, Inc.
Series B Preferred Stock
2018-07-02−1,922,682→ 0 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+1,922,682→ 3,616,951 total
Conversion
Forty Seven, Inc.
Common Stock
2018-07-02+938,489→ 938,489 total
Conversion
Forty Seven, Inc.
Series A-1 Preferred Stock
2018-07-02−938,489→ 0 total
Purchase
Forty Seven, Inc.
Common Stock
2018-07-02$16.00/sh+200,000→ 3,816,951 total
Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2018-01-22+25,000→ 25,000 total
Conversion
Venus Concept Inc.$VERO
Series C Preferred Stock
2017-10-16−3,389,105→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+3,389,105→ 3,389,105 total
Conversion
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-16→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16$7.00/sh+180,881→ 3,569,986 total
Other
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-11$1259269.79/sh
Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2017-01-30+25,000→ 25,000 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-09$0.16/sh−230,507→ 2,214,523 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-08$0.19/sh−103,123→ 2,445,030 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-05$0.20/sh−832,881→ 2,548,153 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-04$0.14/sh−500,026→ 3,381,034 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-03$0.15/sh−82,583→ 3,881,060 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-02$0.17/sh−176,306→ 3,963,643 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-02-01$0.20/sh−140,000→ 4,139,949 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-29$0.26/sh−52,826→ 4,279,949 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-28$0.26/sh−32,521→ 4,332,775 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-27$0.27/sh−209,984→ 4,365,296 total
Sale
TETRALOGIC PHARMACEUTICALS Corp
Common Stock
2016-01-26$0.30/sh−69,425→ 4,575,280 total
Award
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2016-01-25+20,000→ 20,000 total
Exercise/Conversion
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2016-01-06$15.34/sh+15,000→ 41,159 total
Exercise/Conversion
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2016-01-06−15,000→ 0 total
Sale
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2016-01-06$27.50/sh−15,000→ 26,159 total
Sale
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2016-01-04$27.50/sh−300→ 26,159 total
Exercise/Conversion
GLOBUS MEDICAL INC$GMED
Class A Common Stock
2016-01-04$15.34/sh+300→ 26,459 total
Exercise/Conversion
GLOBUS MEDICAL INC$GMED
Stock Option (Right to Buy Class A Common Stock)
2016-01-04−300→ 15,000 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-16$14.30/sh−39,701→ 2,237,377 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-15$14.27/sh−1,529→ 2,277,078 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-12$14.25/sh−6,430→ 2,278,607 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-11$14.27/sh−25,168→ 2,285,037 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-10$14.32/sh−8,987→ 2,310,205 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-09$14.26/sh−13,000→ 2,319,192 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-08$14.25/sh−2,662→ 2,332,192 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-03$14.32/sh−10,450→ 2,334,854 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-02$14.25/sh−11,014→ 2,345,304 total
Sale
Oxford Immunotec Global PLC
Ordinary Shares
2015-06-01$14.29/sh−15,010→ 2,356,318 total

Companies

Recent Filings

Address

C/O CLARUS VENTURES, LLC 101 MAIN STREET, SUITE 1210

CAMBRIDGE, MA, 02142

View on SEC.gov